{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T23:56:09Z","timestamp":1788134169122,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:00:00Z","timestamp":1742083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017956","name":"Gansu Province Health Commission","doi-asserted-by":"publisher","award":["GSWSQNPY2024-12"],"award-info":[{"award-number":["GSWSQNPY2024-12"]}],"id":[{"id":"10.13039\/100017956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012594","name":"Scientific Research Foundation of Shaanxi Provincial Key Laboratory","doi-asserted-by":"publisher","award":["2024-KFMS-2"],"award-info":[{"award-number":["2024-KFMS-2"]}],"id":[{"id":"10.13039\/501100012594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012594","name":"Scientific Research Foundation of Shaanxi Provincial Key Laboratory","doi-asserted-by":"publisher","award":["2023-KFMS-4"],"award-info":[{"award-number":["2023-KFMS-4"]}],"id":[{"id":"10.13039\/501100012594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460722"],"award-info":[{"award-number":["82460722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["25JRRA610"],"award-info":[{"award-number":["25JRRA610"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["2023NYFYSYS008"],"award-info":[{"award-number":["2023NYFYSYS008"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["25JRRA587"],"award-info":[{"award-number":["25JRRA587"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022817","name":"Lanzhou University Second Hospital","doi-asserted-by":"publisher","award":["CYXZ2024-08"],"award-info":[{"award-number":["CYXZ2024-08"]}],"id":[{"id":"10.13039\/100022817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022817","name":"Lanzhou University Second Hospital","doi-asserted-by":"publisher","award":["CY2021-QN-A16"],"award-info":[{"award-number":["CY2021-QN-A16"]}],"id":[{"id":"10.13039\/100022817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022817","name":"Lanzhou University Second Hospital","doi-asserted-by":"publisher","award":["CY2024-MS-A01"],"award-info":[{"award-number":["CY2024-MS-A01"]}],"id":[{"id":"10.13039\/100022817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009620","name":"Gansu Province Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cellsig.2025.111750","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T11:31:14Z","timestamp":1742124674000},"page":"111750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["TAK-901, a novel EPHA2 inhibitor as a therapeutic strategy against prostate cancer"],"prefix":"10.1016","volume":"131","author":[{"given":"Shanhui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2025.111750_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111750_bb0010","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41401-020-00604-1","article-title":"Response prediction biomarkers and drug combinations of PARP inhibitors in prostate cancer","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111750_bb0015","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111750_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111750_bb0025","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.joim.2019.09.004","article-title":"Induction of sub-G(0) arrest and apoptosis by seed extract of Moringa peregrina (Forssk.) Fiori in cervical and prostate cancer cell lines","volume":"17","author":"Abou-Hashem","year":"2019","journal-title":"J. Integr. Med."},{"issue":"22","key":"10.1016\/j.cellsig.2025.111750_bb0030","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for metastatic castration-resistant prostate cancer","volume":"382","author":"de Bono","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111750_bb0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13020-024-00881-6","article-title":"Sanguinarine chloride induces ferroptosis by regulating ROS\/BACH1\/HMOX1 signaling pathway in prostate cancer","volume":"19","author":"Liu","year":"2024","journal-title":"Chin. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111750_bb0040","doi-asserted-by":"crossref","first-page":"19359","DOI":"10.1038\/s41598-024-68565-7","article-title":"Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses","volume":"14","author":"Lopez-Cortes","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111750_bb0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.joim.2024.05.004","article-title":"Cycloastragenol induces apoptosis and protective autophagy through AMPK\/ULK1\/mTOR axis in human non-small cell lung cancer cell lines","volume":"22","author":"Zhu","year":"2024","journal-title":"J Integr Med"},{"key":"10.1016\/j.cellsig.2025.111750_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.steroids.2018.04.005","article-title":"Cycloartane-type sapogenol derivatives inhibit NFkappaB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis","volume":"135","author":"Debelec-Butuner","year":"2018","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111750_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12672-023-00707-1","article-title":"AURKB activates EMT through PI3K\/AKT signaling axis to promote ICC progression","volume":"14","author":"Ma","year":"2023","journal-title":"Discov. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111750_bb0060","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2014.14","article-title":"The aurora kinases in cell cycle and leukemia","volume":"34","author":"Goldenson","year":"2015","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111750_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26071981","article-title":"Aurora kinase B inhibition: a potential therapeutic strategy for cancer","volume":"26","author":"Borah","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111750_bb0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.21873\/anticanres.11335","article-title":"Aurora B inhibitor TAK-901 synergizes with BCL-xL inhibition by inducing active BAX in cancer cells","volume":"37","author":"Murai","year":"2017","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111750_bb0075","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/1535-7163.MCT-12-0657","article-title":"Biological characterization of TAK-901, an investigational, novel, multitargeted Aurora B kinase inhibitor","volume":"12","author":"Farrell","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"23","key":"10.1016\/j.cellsig.2025.111750_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235805","article-title":"The Aurora kinase inhibitor TAK901 inhibits glioblastoma growth by blocking SREBP1-mediated lipid metabolism","volume":"14","author":"Zhan","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111750_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ph17020225","article-title":"Unveiling epigenetic vulnerabilities in triple-negative breast cancer through 3D organoid drug screening","volume":"17","author":"Rao","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.cellsig.2025.111750_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110579","article-title":"Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers","volume":"104","author":"Lau","year":"2023","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111750_bb0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13045-020-00944-9","article-title":"Targeting EphA2 in cancer","volume":"13","author":"Xiao","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2025.111750_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216479","article-title":"Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer","volume":"579","author":"Primeaux","year":"2023","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111750_bb0105","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.21873\/anticanres.13834","article-title":"Elevated expression of EPHA2 is associated with poor prognosis after radical prostatectomy in prostate cancer","volume":"39","author":"Kurose","year":"2019","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111750_bb0110","first-page":"613","article-title":"Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival","volume":"9","author":"Kinch","year":"2003","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"5","key":"10.1016\/j.cellsig.2025.111750_bb0115","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/ijc.31405","article-title":"EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma","volume":"143","author":"Garcia-Monclus","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.cellsig.2025.111750_bb0120","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/cmdc.201700217","article-title":"Chemoproteomics-aided medicinal chemistry for the discovery of EPHA2 inhibitors","volume":"12","author":"Heinzlmeir","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cellsig.2025.111750_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116111","article-title":"SRT1720 inhibits bladder cancer cell progression by impairing autophagic flux","volume":"222","author":"Li","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111750_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2024.119684","article-title":"Raltitrexed induces apoptosis through activating ROS-mediated ER stress by impeding HSPA8 expression in prostate cancer cells","volume":"1871","author":"Tao","year":"2024","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"W1","key":"10.1016\/j.cellsig.2025.111750_bb0135","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111750_bb0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/07853890310014605","article-title":"Cell cycle control, DNA damage checkpoints and cancer","volume":"35","author":"Laiho","year":"2003","journal-title":"Ann. Med."},{"key":"10.1016\/j.cellsig.2025.111750_bb0145","article-title":"Complement is increased in treatment resistant rectal cancer and modulates radioresistance","volume":"604","author":"O\u2019Brien","year":"2024","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111750_bb0150","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00109-020-01895-x","article-title":"The therapeutic potential of Aurora kinases targeting in glioblastoma: from preclinical research to translational oncology","volume":"98","author":"de Almeida Magalhaes","year":"2020","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111750_bb0155","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.leukres.2010.07.034","article-title":"High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia","volume":"35","author":"Lucena-Araujo","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cellsig.2025.111750_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109113","article-title":"Selective inhibition of Aurora A and B kinases effectively induces cell cycle arrest in t(8;21) acute myeloid leukemia","volume":"117","author":"Qi","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111750_bb0165","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41576-019-0150-2","article-title":"RNA sequencing: the teenage years","volume":"20","author":"Stark","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111750_bb0170","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1021\/acs.jproteome.3c00463","article-title":"Highly reproducible quantitative proteomics analysis of pancreatic cancer cells reveals proteome-level effects of a novel combination drug therapy that induces cancer cell death via metabolic remodeling and activation of the extrinsic apoptosis pathway","volume":"22","author":"Rasam","year":"2023","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cellsig.2025.111750_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116249","article-title":"Hainanolide inhibits the progression of colon cancer via inducing the cell cycle arrest, cell apoptosis and activation of the MAPK signaling pathway","volume":"454","author":"Gong","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.cellsig.2025.111750_bb0180","article-title":"Isovalerylspiramycin I suppresses small cell lung cancer proliferation via ATR\/CHK1 mediated DNA damage response and PERK\/eIF2alpha\/ATF4\/CHOP mediated ER stress","volume":"230","author":"Xu","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2025.111750_bb0185","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2020.3","article-title":"DNA damage checkpoint kinases in cancer","volume":"22","author":"Smith","year":"2020","journal-title":"Expert Rev. Mol. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111750_bb0190","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41401-024-01394-6","article-title":"A structure-based virtual screening identifies a novel MDM2 antagonist in the activation of the p53 signaling and inhibition of tumor growth","volume":"46","author":"Hu","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111750_bb0195","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.1038\/s41467-024-52659-x","article-title":"SURF2 is a MDM2 antagonist in triggering the nucleolar stress response","volume":"15","author":"Tagneres","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111750_bb0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s40364-024-00653-2","article-title":"DNA damage response in breast cancer and its significant role in guiding novel precise therapies","volume":"12","author":"Li","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cellsig.2025.111750_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102114","article-title":"Defining the mode of action of cisplatin combined with NUC-1031, a phosphoramidate modification of gemcitabine","volume":"50","author":"Patel","year":"2024","journal-title":"Transl. Oncol."},{"issue":"53","key":"10.1016\/j.cellsig.2025.111750_bb0210","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1038\/sj.onc.1208937","article-title":"A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis","volume":"24","author":"Fang","year":"2005","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.cellsig.2025.111750_bb0215","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1038\/s41388-021-01786-6","article-title":"EphA2-YES1-ANXA2 pathway promotes gastric cancer progression and metastasis","volume":"40","author":"Mao","year":"2021","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111750_bb0220","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41419-021-03538-6","article-title":"EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2","volume":"12","author":"Cui","year":"2021","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111750_bb0225","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41419-022-04984-6","article-title":"Interactions between EGFR and EphA2 promote tumorigenesis through the action of Ephexin1","volume":"13","author":"Kim","year":"2022","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111750_bb0230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T","article-title":"Overexpression of the EphA2 tyrosine kinase in prostate cancer","volume":"41","author":"Walker-Daniels","year":"1999","journal-title":"Prostate"},{"issue":"21","key":"10.1016\/j.cellsig.2025.111750_bb0235","doi-asserted-by":"crossref","first-page":"14623","DOI":"10.1021\/acs.jmedchem.3c01135","article-title":"Development of a (18)F-labeled bicyclic peptide targeting EphA2 for molecular imaging of PSMA-negative prostate cancer","volume":"66","author":"Gan","year":"2023","journal-title":"J. Med. Chem."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825001639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825001639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:27:44Z","timestamp":1762316864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825001639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":47,"alternative-id":["S0898656825001639"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111750","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TAK-901, a novel EPHA2 inhibitor as a therapeutic strategy against prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111750"}}